You are here: Industry Insights > Allergan

News List

Amgen and Allergan announce positive top-line results from comparative clinical study of ABP 798, biosimilar candidate to Rituxan® (rituximab) worldpharmanews
August 23, 2019
Amgen and Allergan plc. announced positive top-line results from a comparative clinical study evaluating the efficacy and safety of ABP 798...
AbbVie was Allergan's only suitor in $63B takeover that shocked the industry fiercepharma
August 15, 2019
AbbVie’s $63 billion, megatakeover agreement for Allergan took most of the industry by surprise when the two drugmakers dropped the news in late June.
Allergan CEO Saunders lines up for $39M parachute after AbbVie buy fiercepharma
August 15, 2019
Allergan CEO Brent Saunders’ meteoric rise through pharma’s chief exec ranks is paying off, and in a big way. If he’s let go after AbbVie’s $63 billion takeover of the California company goes through, Saunders will net a cool $38.7 million.
Whoops! Allergan's bid to shield Botox manufacturing secrets from competitors backfires fiercepharm
August 11, 2019
Allergan has been more than willing to do whatever necessary to protect its secret process for making blockbuster Botox. After filing a trade theft investigation against a competitor, the drugmaker hoped a judge would keep its secrets hush-hush a little l
AbbVie’s $63B Allergan buyout offer depends on Botox growth. But will it last? fiercepharma
August 07, 2019
An enduring medical aesthetics franchise, led by wrinkle-fighter Botox, is one of the key reasons AbbVie is shelling out $63 billion for Allergan. That drug has again pulled off a sales jump, though a slower growth rate suggests a tough game ahead.
Allergan Voluntarily Recalls BIOCELL® Textured Breast Implants and Tissue Expanders prnasia
August 07, 2019
Allergan plc (NYSE: AGN) today announced a voluntary worldwide recall of BIOCELL® textured breast implants and tissue expanders. Allergan is taking this action as a precaution following notification of ...
Allergan Recalls Textured Breast Implants Linked to Lymphoma drugs
July 25, 2019
Allergan's textured breast implants will be recalled due to their link to a rare cancer, the U.S. Food and Drug Administration announced Wednesday.
AbbVie is to acquire Allergan in a ‘transformative transaction’ europeanpharmaceuticalreview
June 28, 2019
AbbVie Inc. and Allergan plc have entered into a definitive transaction agreement under which AbbVie will acquire Allergan.
Analysts rip into AbbVie, Allergan's $63B deal, citing culture clash, strategy concerns and more fiercepharma
June 28, 2019
AbbVie made a major splash Tuesday with its proposed $63 billion buyout of Allergan that’ll create a top-5 pharma giant. But analysts and investors were hardly impressed. One day after the announcement, feedback continues to pour in, with analysts questio
FDA approves Allergan’s BOTOX for upper limb spasticity pharmaceutical-technology
June 26, 2019
The US Food and Drug Administration has approved Allergan’s supplemental biologics application (sBLA) for its BOTOX treatment for paediatric patients with upper limb spasticity.

Previous page 1 2 3 4 5 6 7 8 9 10 11 12 13 Next page